These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 20419305)

  • 1. Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease.
    Portelius E; Bogdanovic N; Gustavsson MK; Volkmann I; Brinkmalm G; Zetterberg H; Winblad B; Blennow K
    Acta Neuropathol; 2010 Aug; 120(2):185-93. PubMed ID: 20419305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
    Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
    Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMY plaques in familial AD: comparison with sporadic Alzheimer's disease.
    Lippa CF; Schmidt ML; Nee LE; Bird T; Nochlin D; Hulette C; Mori H; Lee VM; Trojanowski JQ
    Neurology; 2000 Jan; 54(1):100-4. PubMed ID: 10636133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry.
    Portelius E; Lashley T; Westerlund A; Persson R; Fox NC; Blennow K; Revesz T; Zetterberg H
    Neurodegener Dis; 2015; 15(1):50-7. PubMed ID: 25591542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amyloid-β isoform pattern in cerebrospinal fluid in familial PSEN1 M139T- and L286P-associated Alzheimer's disease.
    Portelius E; Fortea J; Molinuevo JL; Gustavsson MK; Andreasson U; Sanchez-Valle R
    Mol Med Rep; 2012 Apr; 5(4):1111-5. PubMed ID: 22307680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
    Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
    Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.
    Portelius E; Andreasson U; Ringman JM; Buerger K; Daborg J; Buchhave P; Hansson O; Harmsen A; Gustavsson MK; Hanse E; Galasko D; Hampel H; Blennow K; Zetterberg H
    Mol Neurodegener; 2010 Jan; 5():2. PubMed ID: 20145736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
    Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
    Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases.
    Wirths O; Bethge T; Marcello A; Harmeier A; Jawhar S; Lucassen PJ; Multhaup G; Brody DL; Esparza T; Ingelsson M; Kalimo H; Lannfelt L; Bayer TA
    J Neural Transm (Vienna); 2010 Jan; 117(1):85-96. PubMed ID: 19823761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin basic protein associates with AβPP, Aβ1-42, and amyloid plaques in cortex of Alzheimer's disease brain.
    Zhan X; Jickling GC; Ander BP; Stamova B; Liu D; Kao PF; Zelin MA; Jin LW; DeCarli C; Sharp FR
    J Alzheimers Dis; 2015; 44(4):1213-29. PubMed ID: 25697841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease.
    Portelius E; Zhang B; Gustavsson MK; Brinkmalm G; Westman-Brinkmalm A; Zetterberg H; Lee VM; Trojanowski JQ; Blennow K
    Neurodegener Dis; 2009; 6(5-6):258-62. PubMed ID: 19955704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Abeta levels in the brain of familial and sporadic Alzheimer's disease.
    Hellström-Lindahl E; Viitanen M; Marutle A
    Neurochem Int; 2009 Sep; 55(4):243-52. PubMed ID: 19524115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody.
    Antonios G; Saiepour N; Bouter Y; Richard BC; Paetau A; Verkkoniemi-Ahola A; Lannfelt L; Ingelsson M; Kovacs GG; Pillot T; Wirths O; Bayer TA
    Acta Neuropathol Commun; 2013 Sep; 1():56. PubMed ID: 24252153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
    Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
    Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease.
    Sandebring A; Welander H; Winblad B; Graff C; Tjernberg LO
    PLoS One; 2013; 8(2):e55847. PubMed ID: 23409063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease.
    Walter S; Jumpertz T; Hüttenrauch M; Ogorek I; Gerber H; Storck SE; Zampar S; Dimitrov M; Lehmann S; Lepka K; Berndt C; Wiltfang J; Becker-Pauly C; Beher D; Pietrzik CU; Fraering PC; Wirths O; Weggen S
    Acta Neuropathol; 2019 Feb; 137(2):239-257. PubMed ID: 30426203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.
    Gandy S; Petanceska S
    Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.